Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol for reducing blood loss during total abdominal hysterectomy for uterine myoma
IRCT2016122831635N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of misoprostol in Fibromyoma (LM), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Blood loss during total abdominal hysterectomy. Started Apr 2017; status: completed.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT2016122831635N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016122831635N1.